Fact check · Version 1 · Sources checked

“Every product sold as thymosin alpha-1 is equivalent to Zadaxin.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Misleading

This statement leaves out a limit that changes its meaning.

FDA's 2024 review describes Zadaxin as a finished medicine with narrow foreign approval. It is not the same as an ingredient name, a compounded product, or an online product.

What this answer is based on
This answer uses an official regulator record or a specific product label.
Limits of this answer
The exact product, ingredient form, way it was made, and country status all matter. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
Whether evidence for one product also applies to another product.

Sources for this fact check

Show 1 sources
Sources checked by
Site editor · Editorial review

More about Thymosin alpha-1

See the FDA and sports-rule status of Thymosin alpha-1

Other fact checks on Thymosin alpha-1